ACTA1 and plasma cell myeloma: In this regard, other groups have indicated that FSP1+/α-SMA+ CAFs derived from multiple myeloma had low expression of CD90 and a proportion of these cells express the endothelial marker CD31 [42], which has been reported negative in MSCs [27] as we observed in our study.